Valuation : BAYER

Market Cap 4.85TCr 5.63TCr 4.55TCr 4.16TCr 7.77TCr 5,32600Cr 7.83TCr 54TCr 21TCr 2,72200Cr 21TCr 21TCr 8,76500Cr P/E 2026 *
22.4x
P/E 2027 * 16.1x
Enterprise Value 7.84TCr 9.12TCr 7.36TCr 6.73TCr 13TCr 8,61700Cr 13TCr 87TCr 34TCr 4,40300Cr 34TCr 33TCr 14,18200Cr EV / Sales 2026 *
1.71x
EV / Sales 2027 * 1.6x
Free-Float
99.99%
Yield 2026 *
0.32%
Yield 2027 * 1.13%
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 61 01/04/2017
Chairman 68 28/04/2020
Change 5-day change 1-year change 3-year change Capi.($)
-1.15%-2.67%+53.88%+104.81% 1,03400Cr
-0.66%+3.02%+54.47%+71.85% 67TCr
-1.09%+0.78%+20.88%+76.24% 46TCr
+0.14%-0.47%+29.49%+38.56% 35TCr
-1.33%+4.72%+24.69%+45.55% 31TCr
-1.15%+0.30%-1.49%+12.31% 26TCr
-1.25%+1.39%+56.52%+72.60% 24TCr
-0.88%+1.15%-17.09%-54.39% 21TCr
-0.24%+3.28%+33.42%+100.18% 19TCr
Average -0.81%+1.27%+28.31%+51.97% 41.3TCr
Weighted average by Cap. -0.87%+1.04%+36.54%+66.55%

Financials

2026 *2027 *
Net sales 4.58TCr 5.32TCr 4.3TCr 3.93TCr 7.33TCr 5,02900Cr 7.39TCr 51TCr 20TCr 2,57000Cr 20TCr 20TCr 8,27700Cr 4.7TCr 5.46TCr 4.41TCr 4.04TCr 7.53TCr 5,16400Cr 7.59TCr 52TCr 20TCr 2,63900Cr 21TCr 20TCr 8,50000Cr
Net income 213.63Cr 248.29Cr 200.47Cr 183.41Cr 342.33Cr 23TCr 345.04Cr 2.37TCr 923.55Cr 12TCr 932.36Cr 912.03Cr 39TCr 294.11Cr 341.82Cr 275.99Cr 252.51Cr 471.3Cr 32TCr 475.03Cr 3.26TCr 1.27TCr 17TCr 1.28TCr 1.26TCr 53TCr
Net Debt 3TCr 3.48TCr 2.81TCr 2.57TCr 4.8TCr 3,29100Cr 4.84TCr 33TCr 13TCr 1,68200Cr 13TCr 13TCr 5,41700Cr 2.68TCr 3.12TCr 2.52TCr 2.3TCr 4.3TCr 2,94800Cr 4.33TCr 30TCr 12TCr 1,50600Cr 12TCr 11TCr 4,85200Cr
Logo BAYER
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-